Delivery Order SPE2DB22D1202-SPE2DB25FVAM1
Award Date
5/21/25
Potential Completion Date
5/22/25
Potential Value
$5.7K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,951,685 units of dextroamphetamine-amphetamine 20 mg capsules, a prescription medication. The total ceiling value of the contract is $2,246.14, and it is a firm fixed-price contract with an ultimate completion date of April 18, 2025. The contract is not set aside for any...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of 20 mg Dextroamphetamine-Amphetamine capsules, a pharmaceutical product, with a ceiling value of $2,358.04. The contract is a firm fixed-price, non-set-aside award with a performance period through May 23, 2025. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC)...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,568,019,039 units of the prescription medication dextroamphetamine-amphetamine 15 mg capsules, with a ceiling value of $1,528.00. The contract has an ultimate completion date of April 24, 2025 and was awarded on April 23, 2025. It is a firm fixed-price, non-set-aside contract....
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 10 mg Dextroamphetamine-Amphetamine capsules. The contract is a firm fixed-price delivery order with a ceiling value of $3,763.85 and a period of performance through April 2025. There is no set-aside designation, indicating the order was competed openly. AmerisourceBergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Dextroamphetamine-Amphetamine 10mg capsules, with a ceiling value of $1,308.48 and a completion date of May 23, 2025. The contract is a firm fixed-price delivery order, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a significant...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,568,059,549 units of the prescription medication dextroamphetamine-amphetamine 10 mg capsules. The contract is a firm fixed-price, non-set-aside arrangement with a ceiling value of $2,525.52 and a performance period extending through April 29, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,119.60, is for the delivery of 4,568,135,213 units of Dextroamphetamine-Amphetamine 10 mg capsules. The contract is a firm fixed-price, non-set-aside award with a performance period through May 6, 2025. AmerisourceBergen holds a substantial Indefinite Delivery Contract (IDC) with DLA...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,585,317 units of dextroamphetamine-amphetamine 20 mg capsules in 100-count bottles, with a total ceiling value of $1,475.55. The contract has an ultimate completion date of March 17, 2025 and is a firm fixed-price contract. AmerisourceBergen holds a significant Indefinite...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules. The contract has a ceiling value of $4,344.34 and a period of performance ending on March 11, 2024. The contract is a Firm Fixed Price arrangement with no set-aside designation, indicating open competition. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,734.75, is for the supply of 4,567,861,597 units of the prescription medication dextroamphetamine-amphetamine 10 mg capsules. The contract is a firm fixed-price delivery order without any set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a substantial...